InsiderTrades.com logo

FRX Insider Trading

Insider Ownership Percentage: 16.20%
Insider Buying (Last 12 Months): C$330,116.01
Insider Selling (Last 12 Months): C$1,582,823.12

Fennec Pharmaceuticals Insider Trading History Chart

This chart shows the insider buying and selling history at Fennec Pharmaceuticals by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Fennec Pharmaceuticals Share Price & Price History

Current Price: C$10.54
Price Change: ▼ Price Decrease of -0.16 (-1.50%)
As of 12/3/2025 04:59 PM ET

This chart shows the closing price history over time for FRX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365

Fennec Pharmaceuticals Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
10/10/2025Chris Anigeron RallisDirectorBuy4,062C$1.70C$6,905.4057,091
10/10/2025Chris Anigeron RallisDirectorSell1,775C$12.75C$22,631.2555,316
10/9/2025Southpoint Capital Advisors LpInsiderSell20,609C$12.89C$265,650.014,010,100
10/8/2025Rostislav Christov RaykovDirectorBuy4,609C$3.38C$15,578.422,697,927
10/8/2025Southpoint Capital Advisors LpInsiderSell19,605C$13.07C$256,237.354,030,709
10/7/2025Southpoint Capital Advisors LpInsiderSell26,900C$13.23C$355,887.004,050,314
7/7/2025Chris Anigeron RallisDirectorSell1,119C$11.93C$13,352.69
7/7/2025Chris Anigeron RallisDirectorSell2,127C$3.22C$6,847.88
7/3/2025Rostislav Christov RaykovDirectorSell10,000C$11.71C$117,096.00
6/5/2025Rostislav Christov RaykovDirectorSell10,000C$10.66C$106,586.00
6/2/2025Robert Christopher AndradeSenior OfficerBuy8,220C$6.99C$57,433.14
5/19/2025Jeffrey HackmanDirectorBuy15,000C$9.77C$146,580.00
5/16/2025Rostislav Christov RaykovDirectorSell16,667C$9.49C$158,203.16
4/11/2025Chris Anigeron RallisDirectorSell1,409C$6.93C$9,764.37
4/4/2025Rostislav Christov RaykovDirectorSell10,000C$7.46C$74,550.00
3/5/2025Rostislav Christov RaykovDirectorSell7,569C$9.71C$73,503.54
2/14/2025Chris Anigeron RallisDirectorSell1,186C$9.68C$11,485.70
2/5/2025Rostislav Christov RaykovDirectorSell2,431C$9.66C$23,476.17
1/6/2025Rostislav Christov RaykovDirectorSell10,000C$8.76C$87,552.00
12/20/2024Rostislav Christov RaykovDirectorBuy25,000C$3.87C$96,840.00
12/5/2024Rostislav Christov RaykovDirectorBuy796C$8.52C$6,779.05
11/18/2024Robert Christopher AndradeSenior OfficerBuy15,816C$3.43C$54,248.88
10/8/2024Chris Anigeron RallisDirectorSell1,406C$6.16C$8,662.08
10/2/2024Rostislav Christov RaykovDirectorSell2,431C$6.67C$16,212.34
9/4/2024Rostislav Christov RaykovDirectorSell2,431C$7.45C$18,115.81
7/5/2024Chris Anigeron RallisDirectorSell1,173C$6.03C$7,073.19
7/1/2024Rostislav Christov RaykovDirectorSell2,431C$6.13C$14,902.03
4/23/2024Adrian J. HaighSenior OfficerSell22,223C$9.32C$207,029.47
4/15/2024Adrian J. HaighSenior OfficerBuy22,222C$2.31C$51,332.82
4/15/2024Chris Anigeron RallisDirectorSell800C$10.45C$8,360.00
3/26/2024Chris Anigeron RallisDirectorSell2,114C$10.97C$23,190.58
3/26/2024Robert Christopher AndradeSenior OfficerSell13,975C$10.90C$152,345.67
11/24/2023Chris Anigeron RallisDirectorSell269C$8.25C$2,219.25
11/16/2023Khalid IslamDirectorBuy20,492C$2.44C$50,000.48
11/3/2023Rostislav Christov RaykovDirectorBuy74,793C$1.59C$118,920.87
4/28/2023Chris Anigeron RallisDirectorSell916C$8.34C$7,639.44
See Full Table

SEC Filings (Institutional Ownership Changes) for Fennec Pharmaceuticals (TSE:FRX)

11.20% of Fennec Pharmaceuticals stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Fennec Pharmaceuticals logo
Fennec Pharmaceuticals Inc is a clinical-stage biotechnology company. It is primarily engaged in research and development activities. The company is developing Sodium Thiosulfate (STS), a chemo-protectant against hearing loss associated with platinum-based chemotherapy. Its lead product candidate is PEDMARK which is sodium thiosulfate in a novel formulation for the prevention of cisplatin induced hearing loss, or ototoxicity in children.
Read More on Fennec Pharmaceuticals

Today's Range

Now: C$10.54
Low: C$10.51
High: C$10.80

50 Day Range

MA: C$11.90
Low: C$10.54
High: C$13.75

52 Week Range

Now: C$10.54
Low: C$7.02
High: C$13.83

Volume

510 shs

Average Volume

1,085 shs

Market Capitalization

C$359.97 million

P/E Ratio

N/A

Dividend Yield

2.02%

Beta

2.509509

Who are the company insiders with the largest holdings of Fennec Pharmaceuticals?

Fennec Pharmaceuticals' top insider shareholders include:
  1. Southpoint Capital Advisors Lp (Insider)
  2. Rostislav Christov Raykov (Director)
  3. Chris Anigeron Rallis (Director)
  4. Adrian J Haigh (Senior Officer)
  5. Jeffrey Hackman (Director)
  6. Robert Christopher Andrade (Senior Officer)
Learn More about top insider investors at Fennec Pharmaceuticals.